Phenylboronic Acid

Phenylboronic Acid

SCHEMBL18192012

OB(O)c1ccccc1.c1ccc(-n2cnc3ccccc32)cc1

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.74
FGFR1 P11362 6/20 0.61
SRC P12931 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17602704 0.92 FGFR1 (0.68) HTTFGFR1
SCHEMBL2642031 0.88 FGFR1 (0.66) HTTFGFR1
Benzene SCHEMBL14876970 0.86 HTT (1.00) HTTFGFR1
SCHEMBL157265 0.86 HTT (1.00) HTTFGFR1
Iodide SCHEMBL30645138 0.84 HTT (0.96) HTTFGFR1
SCHEMBL27724758 0.84 HTT (0.96) HTTFGFR1
SCHEMBL4891428 0.84 HTT (0.96) HTTFGFR1
SCHEMBL467858 0.84 HTT (0.96) HTTFGFR1
Bicarbonate SCHEMBL2334509 0.83 HTT (0.85) HTTFGFR1
SCHEMBL21647144 0.83 HTT (0.85) HTTFGFR1SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3088392-B1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MAT LTD (KR) 2020-03-11 EP disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 HTT 2080/4885FGFR1 3900/4885SRC 2737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.